| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8724947 | Clinical Gastroenterology and Hepatology | 2018 | 28 Pages |
Abstract
A nationwide long-term cohort study in Taiwan showed that nucleos(t)ide analogue therapy for chronic HBV infection is significantly associated with a reduced ICC risk.
Keywords
CHBNHINHIRDICCIQRALTCCAHCCalanine transaminaseNational Health InsuranceICDCancerbiliaryAntiviralInternational Classification of Diseasesconfidence intervalinterquartile rangehazard rationucleos(t)ide analogueHBVhepatitis B virusNational Health Insurance Research DatabasePreventionHepatocellular carcinomaIntrahepatic cholangiocarcinomaCholangiocarcinoma
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Teng-Yu Lee, Yao-Chun Hsu, Shi-Hang Yu, Jaw-Town Lin, Ming-Shiang Wu, Chun-Ying Wu,